25 studies recruiting now13 research sites across CanadaJoin the community
Home/Conditions/Gastroesophageal Reflux Disease (GERD)
Medical condition

Gastroesophageal Reflux Disease (GERD)

Plain-language information about acid reflux and GERD in Canada, and the research enrolling for it now.
Plain-language guide, not medical advice
Reading time3 min
In Canada1 in 6 adult Canadians
Studies recruitingNone right now

Gastroesophageal reflux disease, or GERD, is acid reflux that keeps happening: stomach contents travelling back up into the food pipe often enough to cause symptoms or damage. Day to day that means burning behind the breastbone, a sour taste in the throat, and symptoms that worsen after meals or lying down.

By the numbers in Canada
1 in 6adult Canadians are affected by gastroesophageal reflux disease, according to the Canadian Digestive Health Foundation, which also reports that about five million Canadians have heartburn or acid regurgitation at least once a week.
Source: Canadian Digestive Health Foundation, 2026
  • Canada has a national recommendation against routine screening endoscopy for reflux alone. The Canadian Task Force on Preventive Health Care recommends not screening adults with chronic GERD for esophageal cancer or for Barrett's esophagus. That does not apply to people with alarm features such as trouble swallowing, bleeding or unexplained weight loss. Source: Canadian Task Force on Preventive Health Care, CMAJ, 2020
  • Esophageal cancer remains uncommon in Canada. The same guideline reports that in 2019 an estimated 6 new cases of esophageal cancer were diagnosed per 100,000 Canadians, at 9 per 100,000 in men and 2 per 100,000 in women. Source: Canadian Task Force on Preventive Health Care, CMAJ, 2020
  • Acid suppressing medicines are among the largest single drug costs to Canadian public plans. In 2017, spending on proton pump inhibitors by public drug programs totalled $198.2 million in Canada. Source: Canadian Digestive Health Foundation, citing CIHI data, 2017
Worldwide709 million people worldwide were estimated to be living with GERD by the Global Burden of Disease study, an age standardised prevalence of 8,818.9 cases per 100,000 population.Source: Institute for Health Metrics and Evaluation, Global Burden of Disease, 2020

What GERD is, and what it is not

Occasional reflux after a large meal is common, and on its own it is not GERD. Emergency Care BC defines GERD as reflux that causes damage or affects quality of life. What matters is not whether reflux happens, but how often.

GERD is also an umbrella term. Erosive esophagitis is a finding rather than a symptom: what a doctor sees at endoscopy when reflux has worn breaks into the lining. Symptoms and damage do not always match. Functional dyspepsia, or indigestion, centres on pain and fullness in the upper abdomen instead. These overlap, so clinicians often assess for more than one at once.

Signs and symptoms

  • Burning in the chest, often after meals or when lying down
  • Sour or bitter fluid coming back up into the throat
  • Chest discomfort that can be mistaken for heart pain
  • A cough, hoarse voice or sore throat that keeps returning
  • Food feeling as though it sticks, or pain when swallowing
  • Nausea, bloating, or sleep broken by symptoms

The pattern differs between people.

An adult standing at home holding a glass of water.
Reflux symptoms are often worse after meals and when lying flat. Illustrative photograph.

What raises the risk

Some risk factors cannot be changed:

  • A hiatus hernia, where part of the stomach sits above the diaphragm
  • A family history of reflux or other digestive symptoms
  • Being male, which the Canadian Digestive Health Foundation lists as a risk factor
  • Pregnancy, and conditions such as scleroderma

Others can often be worked on, usually with support from a health care team:

  • Carrying extra weight, which the same organisation links to GERD
  • Smoking, and alcohol intake
  • Large or late evening meals, and trigger foods such as mint, chocolate, caffeine and spicy or acidic foods

How GERD is diagnosed in Canada

GERD is usually a clinical diagnosis, based on heartburn with or without regurgitation and a review of your medicines, with a trial of acid suppressing medicine. Upper endoscopy, or gastroscopy, is arranged when there are alarm features or when symptoms carry on despite treatment, because it shows whether the lining is eroded and whether Barrett\’s esophagus is present. If the picture stays unclear, a gastroenterologist may add pH monitoring, esophageal manometry or a barium swallow. Endoscopy is not used as a screening test for long standing reflux alone, which the Canadian Task Force on Preventive Health Care recommends against.

Treatment and day-to-day management

Care aims to reduce how much acid reaches the esophagus and keep symptoms manageable. Depending on your history and what any endoscopy showed, a health care team may discuss:

  • Meal timing and size, weight management, reducing smoking, and raising the head of the bed
  • Antacids and alginate products sold without a prescription in Canadian pharmacies
  • Acid suppressing prescription medicines, including H2 receptor antagonists and proton pump inhibitors
  • Endoscopic follow up if erosive esophagitis or Barrett\’s esophagus is found
  • Anti reflux surgery or an endoscopic procedure, for selected people after specialist assessment

These are decisions for you and your own clinician, based on your history and your other medicines.

When to talk to a doctor

  • Chest pain can come from the heart as well as from reflux. Call 911 if chest pain is new or severe, or comes with sweating, breathlessness, faintness, or pain spreading to the arm, jaw or back.
  • Difficulty swallowing, food sticking, or choking.
  • Vomiting blood, black tarry bowel movements, repeated vomiting, or unintended weight loss.
  • Symptoms that keep returning or never settle despite treatment.

Why clinical research matters for GERD

Many people keep having symptoms while already taking standard acid suppressing medicine, and there is no agreement on how that group should be managed. Studies are testing potassium competitive acid blockers, longer acting acid suppression, endoscopic and surgical techniques, and Barrett\’s esophagus surveillance. Researchers are also studying non acid reflux and esophageal hypersensitivity, which may explain why symptoms and visible damage so often fail to match.

Taking part is voluntary. You give informed consent first, you can stop at any time without affecting your regular care, and no one can say in advance whether a study will help you personally.

Learn more from Canadian sources

Where this information comes from (4 sources)
  1. Canadian Digestive Health Foundation, GERD, 2026
  2. Canadian Task Force on Preventive Health Care, screening for esophageal adenocarcinoma in chronic GERD, CMAJ, 2020
  3. Emergency Care BC, GERD: diagnosis and treatment, 2020
  4. Institute for Health Metrics and Evaluation, global burden of gastro-oesophageal reflux disease, 2020

This page is written in plain language for people considering clinical research. It is general health information, not medical advice, and it does not replace a conversation with your own doctor or nurse practitioner.

Common questions

What is the difference between heartburn, GERD, erosive esophagitis and indigestion?

Heartburn is a symptom: burning that rises from the stomach into the chest. GERD is the ongoing condition behind it, where reflux happens often enough to cause symptoms or damage. Erosive esophagitis is a finding rather than a symptom, what a doctor sees at endoscopy when reflux has worn visible breaks into the lining of the esophagus. Functional dyspepsia, which most people call indigestion, centres on pain, burning or fullness in the upper abdomen with no structural cause found. Because they overlap, doctors often look at more than one possibility at once.

Should I be screened for cancer if I have had reflux for years?

The Canadian Task Force on Preventive Health Care recommends against screening adults who have chronic GERD for esophageal cancer or for Barrett's esophagus. That recommendation does not cover people who have alarm features such as trouble swallowing, bleeding, repeated vomiting or unexplained weight loss, or people already known to have Barrett's esophagus, and it does not replace advice about your own situation. Esophageal cancer is uncommon in Canada: the same guideline reports about 6 new cases per 100,000 Canadians in 2019.

Why would someone with reflux be asked to join a clinical trial?

Studies often look for people whose symptoms have not settled with usual acid suppressing treatment, because that is where the biggest open questions are. Joining is voluntary, you give informed consent first, and you can withdraw at any time without affecting your regular care. A research team will explain the study and answer your questions before you decide anything.

What to do next
  1. Talk to your doctor. This guide is information, not medical advice.
  2. Check for a match. Find your study match
  3. Not ready yet? Join the community and we will write to you when something opens.
Clinical research
The JoinAStudy community
Studies for Gastroesophageal Reflux Disease (GERD) open regularly — join the JoinAStudy community and we'll contact you when one may fit.
Join the community →

Learn more about Gastroesophageal Reflux Disease (GERD)

Health blog →

Connecting Canadians with clinical research studies conducted by a network of physicians committed to advancing medicine — since 1995.

JoinAStudy.ca provides information about clinical research and does not provide medical advice, diagnosis, or treatment. Only a qualified study doctor can determine your eligibility for a study. Participation is always voluntary.

© 2026 JoinAStudy.ca · A network of Canadian physicians.|Designed by Pixelore.ca